Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-031283
Filing Date
2011-05-26
Accepted
2011-05-26 16:39:58
Documents
1
Period of Report
2011-05-24

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c17944_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c17944_4x0.xml 4 3892
  Complete submission text file 0001209191-11-031283.txt   5450
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYCLACEL PHARMACEUTICALS, INC. 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address
Banham John Michael Middlecott (Reporting) CIK: 0001357635 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 11874565